Basic Study
Copyright ©The Author(s) 2020.
World J Stem Cells. Feb 26, 2020; 12(2): 152-167
Published online Feb 26, 2020. doi: 10.4252/wjsc.v12.i2.152
Figure 3
Figure 3 ExoCCR2 exerts superior beneficial effects on remyelination and oligodendrogenesis at day 28 after transient middle cerebral occlusion compared to ExoCtrl. A, B: Western blotting analysis of the MBP expression in samples from rats in each group. n = 5, aP < 0.05, bP < 0.01, cP < 0.001; C, D: Analysis of MBP fluorescence intensity in samples from rats in each group. Scale bar = 50 μm, n = 6, aP < 0.05, bP < 0.01, cP < 0.001; E, F: NG2+/ BrdU+ cell colocalization count by immunofluorescence staining. Scale bar = 50 μm, n = 6. bP < 0.01, cP < 0.001.